Cardiac cells integrated into microneedle patches could treat heart attacks
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
List view / Grid view
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
Researchers have developed a method of producing extracellular vesicles on a large scale to deliver drugs offering a standardised method of manufacture...
IRB researchers have developed a method to use a peptide found in chlorotoxin identified in scorpion venom to deliver drugs through the blood-brain barrier...
31 October 2018 | By PerkinElmer
During this webinar, we will investigate trends seen globally for data integrity violations and avenues for remediation...
Pharmaceutical service provider relies on expanded capacities, modular production and modern analytics...
Direct eye injections treat uveitic macular edema more effectively than treatments placed adjacent to the eye, reveals new Mount Sinai research...
Researchers have developed a tiny, soft drug delivery robot with multiple legs, which is capable of handling and carrying heavy loads...
Record entries highlight a big year of innovation in pharma...
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
The crystal structure was found to have a half-life of 24 hours and could last in the bloodstream for more than 96 hours...
Inhibiting protein kinase C-alpha was shown to be a pivotal step towards restoring the damage done by nephritis...